Clinical Experience and Model Analysis on Beta‐2‐Microglobulin Kinetics in High‐Flux Hemodialysis
- 1 September 1993
- journal article
- Published by Wiley in Artificial Organs
- Vol. 17 (9) , 758-763
- https://doi.org/10.1111/j.1525-1594.1993.tb00627.x
Abstract
Beta-2-microglobulin (beta 2M) is associated with amyloidosis. The study of beta 2M kinetics can provide information on the elimination of this uremic toxin. A beta 2M kinetic model modified from Gotch, considering the volume changes between intracellular, interstitial, and intravascular compartments and the generation stimulation and inhibition during hemodialysis is proposed. The clinical experiments on 8 stable hemodialysis patients treated with polysulfone (F80) and polymethyl methacrylate (PMMA, BK2.1p) 3 times a week were conducted. There was an 18% decrease of beta 2M clearance in the period from 30 to 180 min with a time-averaged beta 2M clearance of 48 ml/min using polysulfone dialyzers (F80). In PMMA dialyzers, there was a 64% decrease of beta 2M clearance from 30 to 180 min with a time-averaged clearance of 56.3 ml/min. During hemodialysis, the generation rate was 0.379 mg/min in polysulfone and 0.828 mg/min in PMMA dialyzers. There was a stimulation generation of 0.309 mg/min in polysulfone and 0.749 mg/min in PMMA during hemodialysis. In conclusion, we provide a beta 2M kinetic model including volume changes, polymerization, generation stimulation, and inhibition that is similar to the human physiological condition. This model can be used for further clinical study.Keywords
This publication has 25 references indexed in Scilit:
- Beta2-microglobulin kinetics in end-stage renal failureKidney International, 1991
- Beta-2-Microglobulin Generation Rate and Clearance Rate in Maintenance Hemodialysis PatientsNephron, 1990
- β2-MICROGLOBULIN AND HAEMODIALYSISThe Lancet, 1987
- NO CHANGE IN CORRECTED β2-MICROGLOBULIN CONCENTRATION AFTER CUPROPHANE HAEMODIALYSISThe Lancet, 1987
- HAEMODIALYSIS MEMBRANES, SERUM β2-MICROGLOBULIN, AND DIALYSIS AMYLOIDOSISThe Lancet, 1986
- β2-MICROGLOBULIN-ASSOCIATED AMYLOIDOSIS IN CHRONIC HAEMODIALYSIS PATIENTSThe Lancet, 1986
- Turnover in humans of β2‐microglobulin: the constant chain of HLA‐antigensEuropean Journal of Clinical Investigation, 1980
- The Serum Level and Urinary Excretion of α2-Microglobulin, β2-Microglobulin and Lysozyme in Renal DiseaseScandinavian Journal of Urology and Nephrology, 1972
- Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of β2-microglobulin, albumin, and total proteinJournal of Clinical Investigation, 1969